532612 Stock Overview
Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Indoco Remedies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹332.45 |
| 52 Week High | ₹416.95 |
| 52 Week Low | ₹307.00 |
| Beta | 0.42 |
| 1 Month Change | 0.11% |
| 3 Month Change | -12.72% |
| 1 Year Change | 6.27% |
| 3 Year Change | 2.42% |
| 5 Year Change | 59.72% |
| Change since IPO | 529.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532612 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -5.6% | -2.2% | -2.1% |
| 1Y | 6.3% | 55.3% | 45.3% |
Return vs Industry: 532612 underperformed the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: 532612 underperformed the Indian Market which returned 45.3% over the past year.
Price Volatility
| 532612 volatility | |
|---|---|
| 532612 Average Weekly Movement | 5.2% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 532612 has not had significant price volatility in the past 3 months.
Volatility Over Time: 532612's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1945 | 6,000 | Sundeep Bambolkar | www.indoco.com |
Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. It offers stomatological, gastrointestinal, respiratory, anti-infective, vitamin/mineral/nutrient, ophthal/ontological, antifungal, hormonal, dermatology, urological, anti-diabetic, gynaecological, lifestyle management, pain/analgesic, and cardiac products. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; anti-haemorrhoidals; antacids; antihistaminic; etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services.
Indoco Remedies Limited Fundamentals Summary
| 532612 fundamental statistics | |
|---|---|
| Market cap | ₹30.59b |
| Earnings (TTM) | ₹1.02b |
| Revenue (TTM) | ₹17.96b |
30.1x
P/E Ratio1.7x
P/S RatioIs 532612 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532612 income statement (TTM) | |
|---|---|
| Revenue | ₹17.96b |
| Cost of Revenue | ₹5.95b |
| Gross Profit | ₹12.01b |
| Other Expenses | ₹11.00b |
| Earnings | ₹1.02b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 11.02 |
| Gross Margin | 66.89% |
| Net Profit Margin | 5.66% |
| Debt/Equity Ratio | 46.3% |
How did 532612 perform over the long term?
See historical performance and comparison